Login
$BKHA
$4.94 -$0.46 (8.52%) Close

Consolidated balance sheets

In millions of USD, except per-share amounts
Q3 FY2026
As of Aug 31, 2026
Q2 FY2026
As of May 31, 2026
Q1 FY2026
As of Feb 28, 2026
Q4 FY2025
As of Nov 30, 2025
Q3 FY2025
As of Aug 31, 2025
Q2 FY2025
As of May 31, 2025
Q1 FY2025
As of Feb 28, 2025
Q4 FY2024
As of Nov 30, 2024
Q3 FY2024
As of Aug 31, 2024
Q2 FY2024
As of May 31, 2024
Q1 FY2024
As of Feb 29, 2024
Assets:
Current Assets
Cash
Due from related party
Prepaid expenses
Total Current Assets
Deferred offering costs
Investments held in Trust Account
Total Assets
Liabilities, Shares Subject to Redemption and Shareholders’ Deficit
Current Liabilities
Promissory note – related party
Due to target company
Accrued offering costs and expenses
Due to related party
Due to related party – administrative expenses
Accounts payable and accrued expenses
Accrued interest expenses
Convertible note - related party
Derivative liability - conversion option
Total Current Liabilities
Deferred underwriting fee payable
Total Liabilities
Commitments and Contingencies – see Note 6
Class A ordinary shares subject to possible redemption, $0.0001 par value; 450,000,000 shares authorized; 2,124,077 shares and 2,124,077 shares issued and outstanding at redemption value of $12.24 and $11.22 as of August 31, 2026 and November 30, 2025, respectively
Shareholders’ Deficit
Common stock, value
Common Class A
Common Class B
Total common stock, value
Additional paid-in capital
Accumulated deficit
Total Shareholders’ Deficit
Total Liabilities, Shares Subject to Redemption and Shareholders’ Deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support